ANTI-TL1A ANTIBODY THERAPEUTIC METHODS
Application
US20260078194A1
Kind: A1
Mar 19, 2026
Inventors
Sudhir PENUGONDA, Srini RAMANATHAN, Jason CHAMBERLAIN, Keith HAAN, Mayukh SUKHATME, Frank TORTI, Christopher Ricardo BANFIELD, Deepa E. CHANDRA, Mina HASSAN-ZAHRAEE, Xinli HU, Kenneth HUNG, Craig L. HYDE, Steven W. MARTIN, Srividya NEELAKANTAN, Elena PEEVA, Michael S. VINCENT, Ying WU, Zhan YE
Abstract
The present disclosure provides methods and compositions for determining the risk of a patient being non-responsive to a therapeutic dose of an anti-TNF-like ligand 1A (TL1A) antibody and methods and compositions for treating inflammatory bowel disease (IBD) with a therapeutic dose of an anti-TNF-like ligand 1A (TL1A) antibody.
CPC Classifications
C07K 16/2875
A61K 9/0019
A61K 45/06
A61P 1/00
C12Q 1/6874
C12Q 1/6883
C12Q 1/689
A61K 2039/505
A61K 2039/54
A61K 2039/545
C07K 2317/565
C12Q 2600/106
C12Q 2600/156
Filing Date
2025-11-14
Application No.
19390127